Relapsing Forms of Multiple Sclerosis Completed Phase 2 Trials for Meningococcal polysaccharide vaccine group A (DB13889)

IndicationStatusPhase
DBCOND0036449 (Relapsing Forms of Multiple Sclerosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02097849Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.Treatment